Szostak M Anne - May 6, 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for M. Anne Szostak
Stock symbol
IDXX
Transactions as of
May 6, 2025
Transactions value $
$0
Form type
4
Date filed
5/8/2025, 07:01 PM
Previous filing
Feb 10, 2025
Next filing
May 23, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SZOSTAK M ANNE Director ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for M. Anne Szostak 2025-05-08 0001094176

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +262 $0.00 262 May 6, 2025 Direct
holding IDXX Common Stock 3.06K May 6, 2025 Trust of M. Anne Szostak F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise $0 -262 -100% $0.00 0 May 6, 2025 Common Stock 262 Direct F2
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +600 $0.00 600 May 7, 2025 Common Stock 600 $486.61 Direct F3
transaction IDXX Restricted Stock Unit Award $0 +257 $0.00 257 May 7, 2025 Common Stock 257 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares held by the Trust.
F2 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event was earlier.
F3 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event is earlier.
F4 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event earlier.